2 results
Approved WMOSuspended
In an effort to collect safety and effectiveness information on the stent, Medlogics is conducting the Cobra II study.
Approved WMOCompleted
The primary efficacy objective for this study was to evaluate the efficacy of gantenerumab compared with placebo administered to patients by subcutaneous (SC) injection over 100 weeks as measured by the following co-primary endpoints (final outcome…